期刊文献+

紫杉醇膀胱灌注抑制大鼠膀胱癌生长的机制 被引量:2

The depressant effects and mechanism of intravesical instillation of paclitaxel in rats with bladder cancer
下载PDF
导出
摘要 目的探讨紫杉醇连续膀胱灌注对大鼠膀胱肿瘤生长的作用和机制。方法将40只雌性Wistar大鼠,随机分为对照组(n=20)和紫杉醇组(n=20),制作N-甲基亚硝基脲诱导大鼠原位膀胱癌模型,于第8周分别行生理盐水和紫杉醇制剂连续膀胱灌注,每周1次,共6次。于第14周进行病理观察、测量膀胱总重量,微血管密度(MVD)和凋亡指数(AI)。结果第14周时,对照组(n=16)和紫杉醇组(n=12)大鼠膀胱均可见明显肿物,光镜下可见癌组织侵入肌层。紫杉醇组大鼠膀胱的重量和肿瘤的MVD小于对照组(P<0.01);紫杉醇组大鼠膀胱肿瘤的AI大于对照组(P<0.01)。结论紫杉醇连续膀胱灌注可抑制大鼠膀胱肿瘤生长,可能与抑制肿瘤血管生长和诱导肿瘤细胞凋亡有关。 Objective: To investigate the effects and mechanism of intravesical instillation of paclitaxel in orthotopic bladder tumor of rats. Methods: Forty female Wistar rats were randomized into control group (n = 20) and paclitaxel group (n = 20). Orthotopic bladder tumors were established in rats by intravesical administration of N-mmethyl-noitrosourea. Rats of control and paclitaxel group received a total of six times (every week) intravesical instillation of physiologic saline and paclitaxel respectively from the eighth week. Rats were executed in the fourteenth week and their weights of bladder, pathologic characters, microvessel densities (MVD), apoptotic indexes (AI) were surveyed. Results: There were obvious neoplasms in both control group (n = 18) and paclitaxel group (n= 12) in the fourteenth week. The cells of bladder carcinoma had developed in muscular layes of bladder. The bladder weights and MVDs of paclitaxel group were significantly lower than those in control group (P〈0. 01), but the AI of control group were significantly lower than those in paclitaxel group (P〈0.01). Conclusion: Intravesical instillation of paclitaxel can inhibit the growth of bladder tumour by restraining angiogenesis and accelerating apoptosis in rats.
出处 《陕西医学杂志》 CAS 北大核心 2007年第1期11-13,共3页 Shaanxi Medical Journal
关键词 膀胱肿瘤/药物疗法 膀胱肿瘤/病理学.紫杉属/治疗应用 投药 膀胱内 新生血管化 病理性细胞凋亡 动物 实验 大鼠 WISTAR Bladder neoplasms/drug therapy Bladder neoplasms/pathology Taxus/therapautic use Administration, intravesical Neovascularization, pathologic Animals, laboratoryRats, Wistar
  • 相关文献

参考文献8

  • 1Meyer JP,Persad R,Gillatt DA.Use of bacille calmette-guerin in superficial bladder cancer.Postgrad Med J,2002,78(922):449 被引量:1
  • 2Merchan JR,Jayaram DR,Supko JG,et al.Increased endothelial uptake of paclitaxel as a potential mechanism for its antiangiogenic effects:potentiation by Cox-2 inhibition.Int J Cancer,2005,113(3):490 被引量:1
  • 3Au JL,Kalns J,Gan Y,et al.Pharmacologic effects of paclitaxel in human bladder tumors.Cancer Chemother Pharmacol,1997,41(1):69 被引量:1
  • 4钱立新,刘训良,丁鸿,周建伟,吴宏飞,张炜,虞梅宁.N-甲基亚硝基脲诱导大鼠膀胱肿瘤作用的动态观察[J].中华实验外科杂志,2004,21(5):563-564. 被引量:19
  • 5Lorusso V,Crucitta E,Silvestris N,et al.Randomised,open-label,phase II trial of paclitaxel,gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium.Oncol Rep,2005,13(2):283 被引量:1
  • 6Chen D,Song D,Wientjes MG,et al.Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel.Clin Cancer Res,2003,9(1):363 被引量:1
  • 7Steinberg GD,Brendler CB,Squire RA,et al.Experimental intravesical therapy for superficial transitional cell carcinoma in a rat bladder tumor model.J Urol,1991,145(3):647 被引量:1
  • 8Brown NS,Streeter EH,Jones A,et al.Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species:the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma.Br J Cancer,2005,92(9):1696 被引量:1

二级参考文献2

共引文献18

同被引文献27

引证文献2

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部